Загрузка...
Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
Bevacizumab has been reported to be effective for recurrent glioblastoma. In our hospital, ifosfamide, carboplatin, etoposide (ICE) is the second-line chemotherapy for first recurrence of glioblastoma after temozolomide failure. In the present analysis, we retrospectively investigated the feasibilit...
Сохранить в:
| Опубликовано в: : | Neurol Med Chir (Tokyo) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Japan Neurosurgical Society
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508722/ https://ncbi.nlm.nih.gov/pubmed/24140770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa2013-0211 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|